Striatal dopamine D2 receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Dopamine D(2) receptor availability in the striatum has been reported to be low in generalized social anxiety disorder (GSAD) and obsessive-compulsive disorder (OCD), but it has not been studied in persons with comorbid OCD and GSAD (OCD+GSAD). D(2) receptor availability was assessed in 7 subjects with OCD+GSAD, 8 with OCD, and 7 matched healthy comparison (HC) subjects, all unmedicated adults. D(2) receptor availability was assessed with single-photon emission computerized tomography (SPECT) to measure binding potential (BP) of the D(2) receptor radiotracer [(123)I] iodobenzamide ([(123)I]IBZM). Mean striatal [(123)I]IBZM BP was significantly lower in the OCD+GSAD group (72.58 mL/g, SD=18.17) than in the HC group (118.41 mL/g, SD=45.40; P=.025). Mean BP in the OCD group (93.08 mL/g, SD=36.90) did not differ significantly from the HC group (P=.247). Trait detachment, as measured by the Detachment subscale of the Karolinska Scales of Personality, was negatively correlated with D(2) availability across all subjects (r(s)= -.55, P=.013). Comorbid GSAD and OCD may be associated with decreased availability of D(2) receptors in the striatum, consistent with prior findings in GSAD. Prior findings of decreased D(2) receptor availability in noncomorbid OCD were not confirmed. Decreased D(2) receptor availability was also associated with trait detachment, supporting prior findings in samples of healthy subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liebowitz, M. R. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000414022 · Cited by 2,266
Self-citationMataix-Cols, D., Rauch, S. L., Manzo, P. A., Jenike, M. A., & Baer, L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1409 · Cited by 716
Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration
Morgan, D., Grant, K. A., Gage, H. D., Mach, R. H., Kaplan, J. R., Prioleau, O., Nader, S. H., Buchheimer, N., Ehrenkaufer, R. L., & Nader, M. A. (2002) · Nature Neuroscience · doi:10.1038/nn798 · Cited by 674 · cited 1×
“Preclinical studies have reported parallel findings of lower striatal D2 receptor availability associated with subordinate social state in nonhuman primates [Grant et al., 1998; Morgan et al., 2002].”
ResultMcDougle, C. J., Epperson, C. N., Pelton, G. H., Wasylink, S., & Price, L. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.794 · Cited by 571 · cited 1×
“Treatment with dopamine receptor antagonists is the best-established augmentation strategy for OCD patients refractory to treatment with selective serotonin reuptake inhibitors [SSRIs; Denys et al., 2004a; McDougle et al., 2000].”
BackgroundMawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.-R., Huang, Y., Simpson, N., Ngo, K., Van Heertum, R., et al. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00002 · Cited by 525 · cited 1×
“High-resolution positron emission tomography (PET) and [11C]raclopride could determine whether D2 receptor abnormalities are present in functional subregions of striatum, such as ventral striatum [Mawlawi et al., 2001].”
BackgroundSelf-citationPhenelzine vs Atenolol in Social Phobia: A Placebo-Controlled Comparison
Liebowitz, M. R., Schneier, F., Campeas, R., Hollander, E., Hatterer, J., Fyer, A., Gorman, J., Papp, L., Davies, S., Gully, R., et al. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.49.4.290 · Cited by 444 · cited 2×
“For GSAD, the last mechanism is most compatible with treatment evidence for symptomatic response to some dopaminergic drugs, such as MAOIs [Liebowitz et al., 1992], and emergence of social anxiety during treatment of other disorders with typical and atypical D2 receptor blockers [Mikkelsen et al.,…”
BackgroundResultSelf-citationA placebo-controlled trial of risperidone in Tourette syndrome
Scahill, L., Leckman, J. F., Schultz, R. T., Katsovich, L., & Peterson, B. S. (2003) · Neurology · doi:10.1212/01.wnl.0000055434.39968.67 · Cited by 362 · cited 2×
“, 1992], and emergence of social anxiety during treatment of other disorders with typical and atypical D2 receptor blockers [Mikkelsen et al., 1981; Pallanti et al., 1999; Scahill et al., 2003], although not all studies agree [Barnett et al.”
BackgroundBerridge, K. C., Aldridge, J. W., Houchard, K. R., & Zhuang, X. (2005) · BMC Biology · doi:10.1186/1741-7007-3-4 · Cited by 309 · cited 1×
“Additionally, increasing dopamine transmission in animals by administration of dopamine agonists or by knockdown mutation of the dopamine transporter gene provokes stereotypical behaviors that have been proposed as a model of OCD [Berridge et al., 2005; Szechtman et al., 1998].”
BackgroundDenys, D., de Geus, F., van Megen, H. J. G. M., & Westenberg, H. G. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0803 · Cited by 248
Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder
Denys, D., van der Wee, N., Janssen, J., De Geus, F., & Westenberg, H. G. M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.023 · Cited by 195
Cited by
The locus coeruleus and noradrenergic modulation of cognition
Sara, S. J. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2573 · Cited by 1,848
Neurobiology of rodent self-grooming and its value for translational neuroscience
Kalueff, A. V., Stewart, A. M., Song, C., Berridge, K. C., Graybiel, A. M., & Fentress, J. C. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.8 · Cited by 852
Nikolaus, S., Antke, C., Beu, M., & Müller, H.-W. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.2.119 · Cited by 243
Does cognitive–behavioral therapy for PTSD improve perceived health and sleep impairment?
Galovski, T. E., Monson, C., Bruce, S. E., & Resick, P. A. (2009) · Journal of Traumatic Stress · doi:10.1002/jts.20418 · Cited by 223
Dopaminergic control of cognitive flexibility in humans and animals
Klanker, M., Feenstra, M., & Denys, D. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00201 · Cited by 209
Tian, Y., Baek, J., Lee, S., & Jang, C. (2010) · Synapse · doi:10.1002/syn.20746 · Cited by 197
Genetic determinants of aggression and impulsivity in humans
Pavlov, K. A., Chistiakov, D. A., & Chekhonin, V. P. (2012) · Journal of Applied Genetics · doi:10.1007/s13353-011-0069-6 · Cited by 184
“These observations therefore suggest the important role of D 2 -like receptors and particularly DRD2 in the control of impulsiveness in mammals (Schneier et al. 2008, 2009).”
BackgroundCurrent status of brain imaging in anxiety disorders
Damsa, C., Kosel, M., & Moussally, J. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328319bd10 · Cited by 160
Deep brain stimulation induces striatal dopamine release in obsessive-compulsive disorder
Figee, M., de Koning, P., Klaassen, S., Vulink, N., Mantione, M., van den Munckhof, P., Schuurman, R., van Wingen, G., van Amelsvoort, T., Booij, J., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.06.021 · Cited by 112
Kanen, J. W., Ersche, K. D., Fineberg, N. A., Robbins, T. W., & Cardinal, R. N. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05325-w · Cited by 101
Wiers, C. E., Shokri-Kojori, E., Cabrera, E., Cunningham, S., Wong, C., Tomasi, D., Wang, G.-J., & Volkow, N. D. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.01.056 · Cited by 41
Nikolaus, S., Mamlins, E., Hautzel, H., & Müller, H.-W. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0037 · Cited by 35
Klanker, M., Feenstra, M., Willuhn, I., & Denys, D. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.09.012 · Cited by 25
“OCD is also associated with dysfunctions of the DA system (Denys et al., 2004a, 2004b, 2013; Perani et al., 2008; Schneier et al., 2008).”
Anxiolytic drug discovery: What are the novel approaches and how can we improve them?
Stewart, A. M., & Kalueff, A. V. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.857309 · Cited by 22
“For example, in obsessive-compulsive disorder (OCD), which includes both repetitive behaviors and increased anxiety [14,15], clinical and animal studies have examined the neurochemical, genetic and physiological correlates of these two OCD behaviors [16-18].”
BackgroundDopamine Type 2/3 Receptor Availability in the Striatum and Social Status in Human Volunteers
Martinez, D., Orlowska, D., Narendran, R., Slifstein, M., Liu, F., Kumar, D., Broft, A., Van Heertum, R., & Kleber, H. D. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.037 · Cited by 146
“Striatal D2/3 receptor availability has also been shown to correlate with measures of social detachment in healthy human volunteers and is low in patients with social phobia (7,18-20).”
Self-citation
Metadata
- Authors
- Schneier, F. R., Martinez, D., Abi-Dargham, A., Zea-Ponce, Y., Simpson, H. B., Liebowitz, M. R., & Laruelle, M.
- Venue
- Depression and Anxiety
- Publisher
- Hindawi Limited
- Published
- 2008-01
- Volume
- 25
- Issue
- 1
- Pages
- 1-7
- ISSN
- 1091-4269 (ISSN-L)
- 1520-6394
- OpenAlex
- W2022652429
- Cited by
- 100
- References
- 14
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.